An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors

Chao Shan, Xuping Xie, Antonio E. Muruato, Shannan L. Rossi, Christopher M. Roundy, Sasha R. Azar, Yujiao Yang, Robert B. Tesh, Nigel Bourne, Alan D. Barrett, Nikos Vasilakis, Scott C. Weaver, Pei Yong Shi

    Research output: Contribution to journalArticlepeer-review

    217 Scopus citations

    Abstract

    The Asian lineage of Zika virus (ZIKV) has recently caused epidemics and severe disease. Unraveling the mechanisms causing increased viral transmissibility and disease severity requires experimental systems. We report an infectious cDNA clone of ZIKV that was generated using a clinical isolate of the Asian lineage. The cDNA clone-derived RNA is infectious in cells, generating recombinant ZIKV. The recombinant virus is virulent in established ZIKV mouse models, leading to neurological signs relevant to human disease. Additionally, recombinant ZIKV is infectious for Aedes aegypti and thus provides a means to examine virus transmission. The infectious cDNA clone was further used to generate a luciferase ZIKV that exhibited sensitivity to a panflavivirus inhibitor, highlighting its potential utility for antiviral screening. This ZIKV reverse genetic system, together with mouse and mosquito infection models, may help identify viral determinants of human virulence and mosquito transmission as well as inform vaccine and therapeutic strategies.

    Original languageEnglish (US)
    Pages (from-to)891-900
    Number of pages10
    JournalCell Host and Microbe
    Volume19
    Issue number6
    DOIs
    StatePublished - Jun 8 2016

    Keywords

    • Zika virus
    • antiviral drug discovery
    • flavivirus
    • genetic system
    • mosquito transmission
    • viral virulence

    ASJC Scopus subject areas

    • Parasitology
    • Microbiology
    • Virology

    Fingerprint

    Dive into the research topics of 'An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors'. Together they form a unique fingerprint.

    Cite this